6 Myths About Running a Profitable Independent Pharmacy

Ask a room of pharmacy owners what drives profit and you will hear a lot of confident, and often wrong, answers. The economics of community pharmacy have changed faster than the folk wisdom has. Here are six myths worth retiring, and what the numbers actually say.

This is written for community pharmacy broadly, so the lessons hold across Australia, the UK, and Europe.

Myth 1: Dispensing volume is where the money is

Reality: dispensing is the foundation, not the profit centre. Margins on prescriptions are thin and largely set by government, so each extra script adds work for a small, fixed reward. A meaningful share of income already comes from elsewhere. In Australia, about 30 percent of the average pharmacy’s revenue is retail and over-the-counter, where you actually control the price.

Myth 2: Independent pharmacy is a dying business

Reality: the model is changing, not dying. Despite constant pressure on dispensing margins, average community pharmacy profits in Australia more than doubled over the past decade. Europe still has 160,000 community pharmacies, the great majority independents, and they are expanding into services, not retreating. The businesses that struggle are the ones standing still.

Myth 3: To earn more, you have to dispense more

Reality: value beats volume. Because the reward per script is capped, the fastest route to a better bottom line is usually not more prescriptions but more margin per patient: a vaccination, a paid consultation, a well-chosen retail range. The same patient, served more fully, is worth more than a longer queue.

Myth 4: You just need to hire your way out of the pressure

Reality: the staff are not there to hire. Workforce shortages are structural, and we work through what to do when you cannot hire. The workforce is stretched thin: nearly one in two pharmacists report significant emotional exhaustion, a driver of turnover, and shortages are reported across Australia and Europe. Profitability increasingly depends on using the team you have more effectively, not on finding more people.

Myth 5: Automation is only for big chains

Reality: independents often gain the most. A large chain can absorb an unanswered phone across many sites. For a single pharmacy, one person pulled off the counter to take a routine call is a real cost. Software that answers those calls or handles repetitive admin levels the field, and it no longer requires a chain’s budget to adopt.

Myth 6: The front of shop is dead

Reality: it is where your pricing freedom lives. Retail and OTC are not regulated the way prescriptions are, which is exactly why they matter to profit. The pharmacies losing here are the ones trying to out-discount a supermarket. The ones winning curate ranges for their patients and convert the script handover into a second sale.

What actually drives profit

Strip away the myths and a pattern remains. Profitable independents treat dispensing as the anchor, grow the margin they earn per patient through services and retail, and protect their scarcest resource, staff time, fiercely.

That last point is where most of the hidden leakage sits. Time lost to routine phone calls and admin is time not spent on the higher-margin work. Krepko builds Emily, an AI voice agent that answers routine pharmacy calls so the team is free for the work that actually moves the bottom line. If you want the practical version of this, our revenue streams checklist is a good next read, along with what our call data says about demand for pharmacy delivery and how much of it never gets recorded.